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APOBEC3G (A3G) is a host cytidine deaminase that
inhibits retroviruses. HIV and related primate lentivi-
ruses encode Vif, which counteracts A3Gby inducing
its degradation. This Vif-mediated A3G inhibition is
species specific, suggesting that the A3G-Vif inter-
action has evolved as primate lentiviruses have
adapted to their hosts. We examined the evolu-
tionary dynamics of the A3G-Vif interaction within
four African green monkey (AGM) subspecies, which
are each naturally infected with a distinct simian
immunodeficiency virus (SIV). We identified single
amino acid changes within A3G in two AGM subspe-
cies that render it resistant to Vif proteins, except for
Vif from the viruses that naturally infect these sub-
species. Moreover, experimental infection of AGMs
shows that Vif can rapidly adapt to these arising
Vif-resistant A3G genotypes. These data suggest
that despite being generally nonpathogenic in its
natural host, SIV infection selects for Vif-resistant
forms of A3G in AGM populations, driving Vif coun-
terevolution and functional divergence.
INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1) and HIV-2
originated from multiple cross-species transmissions of SIVs
that naturally infect nonhuman primates in Africa (Hahn et al.,
2000). Although many natural SIV infections exhibit species
specificity, suggestive of coevolution between virus and host,
new viral lineages arise through cross-species transmission
and subsequent rounds of virus-host adaptation (Charleston
and Robertson, 2002; Holmes, 2008). The adaptation of primate
lentiviruses to new hosts is influenced by cell-intrinsic host
restriction factors that impose species-specific barriers to viral
replication (Malim and Emerman, 2008).
One such restriction factor is APOBEC3G (A3G), a cytidine
deaminase that inhibits a broad range of retroviruses and retro-
transposons (Sheehy et al., 2002). Of the seven members of theCell HAPOBEC3 family in humans (A3A–A3H), A3G exhibits the most
robust antiviral activity against HIV-1 and is actively expressed
in relevant host cells targeted by the virus (Koning et al., 2009;
Miyagi et al., 2010; Vetter et al., 2009). On the other hand, retro-
viruses have evolved various mechanisms to overcome the anti-
viral activity of A3G; for example, most lentiviruses encode the
accessory protein Vif, which carries out the accelerated degra-
dation of A3G via the proteasome by linking it to a cellular E3
ubiquitin ligase complex (Goila-Gaur and Strebel, 2008). Antag-
onism of A3G by Vif can occur in a species-specific manner,
suggesting that the specificity of Vif reflects adaptation to the
host (Bogerd et al., 2004; Mariani et al., 2003; Xu et al., 2004).
The natural SIV infections of African green monkeys (AGMs)
provide a unique opportunity to assess how host antiviral genes
impact the evolution of lentiviruses and vice versa. AGMs are the
most abundant nonhuman primates in Africa, occupying ranges
spanning most of the continent south of the Sahara (Wolfheim,
1983). The AGM species (Chlorocebus aethiops) is subdivided
into four subspecies commonly known as sabaeus, vervet,
tantalus, and grivet monkeys. Despite sharing a recent common
ancestor 1–3 million years ago (Perelman et al., 2011; Wertheim
and Worobey, 2007), each subspecies is naturally infected with
a distinct subtype of SIV, aptly named after the specific host it in-
fects: SIVagm.Sab, SIVagm.Ver, SIVagm.Tan, and SIVagm.Gri,
respectively (Peeters and Courgnaud, 2002). SIVagm infection
is widely believed to result in an asymptomatic, nonpathogenic
chronic infection in its natural host (Sodora et al., 2009). There-
fore, the host-virus associations in these primates provide a
setting to study how viral subtypes have diverged over time as
a result of host-specific adaptation in the absence of severe
pathogenesis.
In this study, we examine the coevolution of A3G-Vif interac-
tions. We identify adaptive single-nucleotide polymorphisms
(SNPs) in A3G that allow the antiviral factor to evade destruction
by SIVagm Vif, which in turn has triggered Vif counterevolution in
a subspecies-specific manner. These data argue that SIV infec-
tion selects for Vif-resistant forms of A3G in AGMs. Furthermore,
in an in vivo experimental evolution study, we show that SIVagm
Vif proteins evolve specificity that reflects the A3G genotype
of the host population, implicating the viral gene as a key
accessory to the process of host-specific viral adaptation.
Our data highlight the conflict-driven dynamics of host-virus
arms races and prompt a reexamination of how primateost & Microbe 11, 91–98, January 19, 2012 ª2012 Elsevier Inc. 91
Figure 1. Phylogenetic Analysis of Partial Mitochondrial Genomes and APOBEC3G
The evolutionary relationship between AGMsamples was inferred by BayesianMCMCphylogenetic reconstruction as described in the Experimental Procedures.
Sequence IDs are color coded according to legend to indicate AGM subspecies of origin. Rhesus macaque DNA was used as an outgroup. Ancestral outgroup
branch length is shortened due to space constraints. Scale bars indicate an arbitrary unit of time, relative to 1.
(A) Partial mitochondrial DNA sequences. Asterisks (*) mark nodes with posterior probability scores ofR0.9. Open boxes represent sequences already present
in GenBank, while filled boxes represent sequences identified in this study.
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Figure 2. AGM A3G Variants Maintain Potent Restriction of
Lentiviruses
Single-round viral infectivity assays were performed with virus produced in the
presence or absence of A3G proteins. Error bars indicate standard deviation
from the mean of three infection replicates.
(A) Infectivity of Vif-deficient SIVagm.Tan and HIV-1 (SIVagm.TanDVif and
HIV-1DVif). Infectivity in the absence of A3G was normalized to 100%
(No A3G), while infectivity in the presence of human A3G served as a positive
control for virus restriction. Anti-HAwestern blot analysis was used tomeasure
expression of AGM A3G variants in 293T cells. Anti-b-actin served as protein-
loading controls.
(B) Infectivity of HIV-1DVif and HIV-1 expressing SIVagm Vif in the
presence of AGM A3G variants I-VI. HIV-1:SIVagm.Ver Vif is in red bars;
HIV-1:SIVagm.Tan Vif is in blue bars; HIV-1:SIVagm.Gri Vif is in green bars; and
HIV-1:SIVagm.Sab Vif is in yellow bars. See also Table S2.
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infections.
RESULTS
APOBEC3G Is Highly Polymorphic among AGM
Subspecies
Since Vif sequences are among the most divergent viral genes
across all lineages of SIV (Peeters and Courgnaud, 2002), we
hypothesized that Vif divergence takes place as an adaptive
response to differences in the A3G repertoire of primate hosts.
To determine the degree of A3G diversity in different AGM
subspecies, we sequenced the gene from 40 unique AGM indi-
viduals representing the four major subspecies (see Table S1
available online). Mitochondrial genes (mtDNA) were also se-
quenced in order to confirm the subspecies of origin of each
AGM sample. AGM mtDNA sequences exhibited monophyly;
sequences derived from the same AGM population clustered
together to form clades related by common ancestry (Figure 1A).
In contrast, A3G sequences from any given AGM subspecies are
paraphyletic (Figure 1B), indicating that the evolutionary history
of A3G is incongruent with the species phylogeny.
Virtually every polymorphism in AGM A3G yields an amino
acid replacement—we identified 28 nonsynonymous SNPs
(nsSNPs) present in more than one individual, 16 of which
were observed with a minor allele frequency of 5% or greater
(Figure 1C). In contrast, only one prevalent synonymous SNP
was found, and it was tightly linked with a neighboring nsSNP.
The heavy bias of nonsynonymous changes in AGM A3G is
suggestive of adaptive evolution by natural selection. There-
fore, to address the consequences of AGM A3G polymorphism,
we selected two haplotypes from each of the four subspecies
for functional analysis (Figures 1B and 1C). A3G haplotypes
were cotransfected with proviral lentiviruses in single-round
infectivity experiments to measure their inherent antiviral
activity. In this assay, the infectivity of each virus produced in
the absence of A3G is normalized to 100%. Hereafter, the
proteins encoded by A3G haplotypes are referred to as A3G
variants.
Our results indicate that each A3G variant exhibits strong
restriction of SIVagm.TanDVif and HIV-1DVif (Figure 2A),
decreasing viral infectivity on average by approximately 150-
fold. For comparison, HIV-1DVif infectivity was inhibited about
140-fold by human A3G. These data suggest that there is exten-
sive polymorphism in AGM A3G, and that this diversity does not
affect intrinsic antiviral activity against lentiviruses.
Evidence for Antagonism-Driven Evolution of A3G
in AGMs
In order to address whether the polymorphism in AGM A3G
affects susceptibility to the viral antagonist Vif, we constructed
four recombinant HIV-1 proviruses expressing Vif from the
following SIVagm subtype viruses: SIVsab-1 (Jin et al., 1994),(B) Full-length A3G sequences from AGMs. Asterisks (*) mark nodes with post
functional analysis are indicated by I-VIII.
(C) Sixteen nsSNPs observed at a frequencyR5% are indicated according to am
and the C-terminal cytidine deaminase domain (CD2). The eight AGM A3G haplot
amino acid changes at these positions. See also Table S1.
Cell HSIVgri.667 (Fomsgaard et al., 1991), SIVver90 (Hirsch et al.,
1995), and SIVtan.1 (Soares et al., 1997). A3G haplotypes were
cotransfected with HIV-1 provirus expressing SIVagm Vif, and
virus infectivity was assayed in single-cycle infections. The anti-
viral activity of A3G variants I-VI is readily counteracted by
viruses encoding each SIVagm Vif protein, resulting in a rescue
of viral infectivity that approaches levels observed in the absenceerior probability scores of R0.5. Eight distinct A3G haplotypes selected for
ino acid position, relative to the N-terminal cytidine deaminase domain (CD1)
ypes selected for functional analysis encode proteins that are differentiated by
ost & Microbe 11, 91–98, January 19, 2012 ª2012 Elsevier Inc. 93
Figure 3. Vif-Resistance Phenotype of AGM A3G Maps to Residues
128 and 130 of the Putative Vif Binding Site
(A) The presence of A3G haplotypes in AGM subspecies is indicated by
checked boxes. AGM A3G haplotypes VII and VIII, exclusive to grivet and
sabaeus monkeys, respectively, are distinguished by a negatively charged
glutamic acid at residue 128, and a positively charged histidine at residue 130,
respectively. Human A3G encodes a negatively charged aspartic acid at
residue 128.
(B) Single-round viral infectivity assays were performed with HIV-1DVif and
HIV-1 expressing SIVagm Vif in the presence of AGM A3G variants VII K128E
and VIII D130H. Error bars indicate standard deviation from the mean of three
infection replicates.Mutagenesis of sites 128 and 130 restored Vif sensitivity to
Vif-resistant AGM A3G variants VII K128E and VIII D130H, respectively.
(C) Anti-HA western blot analysis of A3G from cell lysates cotransfected with
HIV-1 encoding different Vif proteins. Anti-b-actin served as protein loading
control.
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tained in haplotypes I-VI do not affect sensitivity to Vif.
Haplotypes VII and VIII are unique in that they encode single
amino acid changes at codons 128 and 130, respectively (Fig-
ure 3A), which in the context of the motif 126FWKPDYQ132 have
been implicated in the interaction between human A3G and
HIV-1 Vif (Huthoff and Malim, 2007; Xu et al., 2004). We found
that variant VII is resistant to Vif from SIVagm.Ver, SIVagm.Tan,
and SIVagm.Sab (sensitive only to SIVagm.Gri Vif), while variant
VIII is also resistant to Vif from SIVagm.Ver and SIVagm.Tan
(Figure 3B). Interestingly, haplotypes VII and VIII are confined
to single subspecies of AGMs (the grivet and sabaeus monkeys,
respectively) at an allele frequency of 20% (4/20 chromosomes
per subspecies) (Figure 3A).
To demonstrate that the Vif resistance exhibited by these two
variants of A3G (henceforth referred to as variants VII K128E and
VIII D130H) is conferred by single residue changes at sites 128
and 130, respectively, we performed site-directed mutagenesis
to revert the amino acid at these sites to the more common resi-
dues present in variants I–VI. An E128K change rendered variant
VII K128E fully susceptible to all four SIVagm Vif proteins, con-
firming the importance of this site for Vif recognition (Figure 3B).
Similarly, a H130D mutation rendered variant VIII D130H fully
sensitive to SIVagm Vif (Figure 3B). Western blot analysis
shows that antagonism of A3G variants by Vif results in deple-
tion of intracellular A3G protein. A3G variants VII K128E and
VIII D130H are effectively degraded by SIVagm.Gri Vif and
SIVagm.Sab Vif, respectively, but not by SIVagm.Ver Vif (Fig-
ure 3C). Furthermore, the revertant mutations E128K and
H130D confer sensitivity to degradation by SIVagm.Ver Vif,
mirroring the results of the infectivity rescue experiments (Fig-
ure 3C). Thus, standing variation in the A3G locus of AGMs is
adaptive, as it allows the antiviral factor to evade destruction
by the viral antagonist, Vif. Furthermore, the different specific-
ities exhibited by SIVagm Vif proteins demonstrate that SIVagm
lineages have coadapted to distinct versions of A3G in AGM
subspecies.
Experimental Adaptation of SIVagm to Vif-Resistant
Forms of AGM A3G In Vivo
Retrospective studies of virus evolution allow one to infer adap-
tations to a host, but do not address the time frame in which this
occurs. On the other hand, prospective studies in which the time
of infection is known can be powerful tools in understanding the
dynamics of viral adaptation. We took advantage of an experi-
mental evolution study in which the impact of A3G variation on
SIVagm evolution could be evaluated within the time frame of
single infected animals. In a previous study, sabaeus monkeys
were experimentally infected with SIVagm.Ver90 and plasma
viremia was monitored in infected sabaeus monkeys for nearly 2
years (Goldstein et al., 2006). We genotyped the A3G locus in
these animals and found that monkey V005 is homozygous for
A3G haplotype VIII D130H, which is resistant to SIVagm.Ver90
Vif (Figure 3B), while monkey V038 is heterozygous for D130H.
Moreover, monkey U964 is homozygous for A3G D130, which
is found in A3G variants that are sensitive to SIVagm.Ver90 Vif
(Figure 2B). As this Vif is derived from the same virus used to
inoculate themonkeys experimentally, we anticipated a scenario
in which restriction by a Vif-resistant form of A3Gwould select for94 Cell Host & Microbe 11, 91–98, January 19, 2012 ª2012 Elsevier Ia functional form of Vif in vivo. Thus, we had the opportunity to
track Vif evolution in monkeys expressing different A3G variants.
We amplified Vif from plasma viral RNA isolated 6–12 months
postinfection. Phylogenetic analysis of >10 viral sequences pernc.
Figure 4. Experimental Adaptation of SIVagm to
Vif-Resistant Forms of AGM A3G In Vivo
(A) Vif sequences amplified by nested RT-PCR were
aligned and subjected to phylogenetic analysis. An
unrooted, neighbor-joining plot was generated after
1,000 iterations, with bootstrap values indicated above
branches. The scale bar indicates the number of nucleo-
tide substitutions per site. Vif sequences from animals
V038, U964, and V005 are represented by open squares,
circles, and triangles, respectively. The sequence for
SIVagm.Ver90 Vif is included to show proximity to the
hypothetical ancestor. Stars indicate sequences cloned
into the HIV-1DVif background and tested for activity
against A3G. See also Figure S1 for Vif alignments.
(B) (Left) Single-round viral infectivity assays were per-
formed with virus produced by coexpressing these
HIV-1:SIV Vif proviral plasmids with AGM A3G variant VIII
D130H. The plotted points per column correspond to
infectivity experiment replicates performed with viruses
encoding Vif isolated from monkey plasma (each virus
replicated two to four times) except in the case of No Vif,
SIVsagm.Sab Vif, and SIVagm.Ver Vif, in which plotted
points represent four independent experiments using the
same virus. HIV-1DVif is denoted by black circles. Vif from
SIVagm.Sab is denoted by black squares, SIVagm.Ver by
black triangles, V005 (two copies of D130H) by white
triangles, V038 (one copy of D130H) by white squares, and
U964 (zero copies of D130H) by white circles. Horizontal
bars indicate the mean relative infectivity. P values were
calculated using a one-way ANOVA test, relative to SI-
Vagm.Ver90 Vif. (Right) Single-round viral infectivity
assays were performed with virus produced by coex-
pressing the same HIV-1:SIV Vif proviral plasmids with Vif-
sensitive AGM A3G variant VI, encoding D130.
(C) Single-round viral infectivity assays were performed
with virus produced by coexpressing HIV-1DVif or
HIV-1:SIV Vif proviral plasmids in the presence of de-
creasing concentrations of AGM A3G variant VIII D130H.
Each point corresponds to the mean infectivity of three to
five viruses encoding different Vif proteins, each replicated
two to four times, except in the case of No Vif, SIVagm.Sab
Vif, and SIVagm.Ver Vif.
(D) Western blot analysis was used to measure A3G
protein expression in cells (upper panel) and encapsidated
in virions (lower panel) after cotransfection with HIV-1
encoding Vif derived from animals V005 and U964. Anti-
b-actin served as cellular protein loading controls.
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with Vif from monkeys V005 (H130/H130) and U964 (D130/
D130) exhibiting monophyly and Vif from V038 (D130/H130)
forming two distinct clades (Figure 4A). An alternate topology
in which V038 Vif sequences share a single ancestor was re-
jected by the SH test (p = 0.006) (Shimodaira and Hasegawa,
1999). The SIVagm.Ver90 Vif sequence lies near the hypothetical
ancestor generated by the analysis. Three to five unique Vif
sequences that were representative of the diversity seen within
each monkey were cloned into an HIV-1 backbone, and their
ability to antagonize A3G variant VIII D130H in single-round
infectivity assays was measured (Figure 4A, black stars).Cell HAll three Vif isolates derived from an infected monkey ex-
pressing two copies of A3G variant VIII D130H (V005) exhibited
robust antagonism of this variant, conferring a 38-fold increase
in viral infectivity on average relative to the unadapted control
SIVagm.Ver90 Vif (p < 0.001) (Figure 4B, left, white triangles).
By comparison, Vif isolated from monkeys expressing one or
zero copies of the haplotype VIII D130H (monkeys V038 and
U964, respectively) did not demonstrate elevated antagonism
of this A3G variant relative to SIVagm.Ver90 Vif (p > 0.05) (Figure
4B, left, white circles and white squares). We found that all of the
in vivo Vif isolates antagonized the AGM A3G haplotype VI
encoding the ancestral D130 allele, with the exception of someost & Microbe 11, 91–98, January 19, 2012 ª2012 Elsevier Inc. 95
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these results demonstrate that the Vif sequences tested encode
functional proteins, and moreover, that observed differences in
antagonism are due to changes that alter specificity for the
A3G substrate.
We also expressed Vif isolates in the presence of different
amounts of A3G variant VIII D130H. Again, we observed that
Vif from amonkey homozygous for this haplotype (V005) exhibits
robust antagonism at all concentrations of A3G (Figure 4C, white
triangles). However, the adaptation is partial, as infectivity is not
rescued to the same degree as SIVagm.Sab Vif, the fully adapted
control that has undergone repeated transmission cycles within
wild sabaeus populations (Figures 4B and 4C, black squares).
Conversely, Vif from the heterozygous monkey (V038) and the
monkey homozygous for D130 (U964) do not antagonize variant
VIII D130H at any concentrations relative to SIVagm.Ver90 Vif
(Figure 4C, white squares and white circles versus black trian-
gles). Consistent with the infectivity data, V005 Vif effectively
degrades A3G variant VIII D130H and excludes it from virions,
while Vif from U964 does not (Figure 4D). Therefore, there is
evidence of adaptation in the Vif gene upon infection of a single
animal, the extent of which is influenced by the host A3G
genotype.
Amino acid alignment of all Vif sequences isolated from these
monkeys reveals a number of recurrent mutations that arose
during the time course of infection, and in some cases, the
samemutation appeared independently in different animals (Fig-
ure S1A). However, only one mutation (Y84C) was observed in
100% (10/10) of Vif isolates frommonkey V005, but not in a single
Vif obtained from the other two monkeys. Interestingly, the
equivalent change is not observed in SIVagm.Sab Vif, demon-
strating that Vif may adapt via a number of distinct evolutionary
trajectories (Figure S1B).
DISCUSSION
We present evidence that A3G is adaptively diversifying within
AGMs as a result of antagonism-driven evolution, suggesting
a history of ongoing host-virus conflict. Specifically, we found
two sites located in the Vif binding site of A3G that are function-
ally polymorphic in AGMs: high frequency, charge-altering SNPs
at residues 128 and 130 alter the sensitivity of A3G to Vif, allow-
ing the antiviral factor to evade antagonism. In response to
changes in host A3G,we demonstrate using both natural isolates
and experimental evolution in vivo that the viral-encoded Vif
protein must itself adapt to retarget the restriction factor and
carry out its destruction. We predict that the genetic conflict
between these two proteins drives continuous evolution in Vif,
which contributes to the species specificity of natural SIV
infections.
Selection Costs Incurred by Apparently
‘‘Nonpathogenic’’ Viruses
Evolutionary studies indicate that A3G is rapidly evolving in
different primate species through a process of positive selection
(Ortiz et al., 2006; Sawyer et al., 2004). The Vif-resistant SNPs
K128E and D130H were observed at 20% frequency in A3G of
the grivet and sabaeus subspecies, respectively, suggesting
that they have emerged recently relative to other polymorphisms96 Cell Host & Microbe 11, 91–98, January 19, 2012 ª2012 Elsevier Ithat were identified in multiple AGM subspecies. Despite the
evidence that contemporary infections result in a nonpathogenic
outcome, the appearance of adaptive genetic changes in the
host implies that SIV infection has exerted selective pressure in
at least some AGM populations. It is possible that selection
imparted by SIVagm may manifest overtly as progressive dis-
ease and immunodeficiency in some monkeys. In support of
this, immunodeficiency has been observed in captivity among
models of ‘‘natural’’ SIV infection (Ling et al., 2004; Pandrea
et al., 2009; Traina-Dorge et al., 1992). The virus may also affect
fitness more subtly by reducing female fertility, influencing mate
choice, or increasing infant mortality (Keele et al., 2009). Alterna-
tively, SIVagm may have been pathogenic to AGM hosts in
the past. Even so, our characterization of the ongoing genetic
conflict between SIVagm and AGMs suggests that other
‘‘nonpathogenic’’ primate lentiviruses may select for adaptive
changes in their respective host species as well.
Paraphyletic Phylogeny of A3G in African GreenMonkey
Subspecies and Vif Selection
The failure of A3G sequences to fully segregate by AGM subspe-
cies may result from demographic and/or stochastic processes.
For example, male-biased migration of AGMs between neigh-
boring reproductive groups can lead to rampant gene flow in
nuclear genes but not in mtDNA, which is maternally inherited
from the more sedentary AGM females (Isbell et al., 1993). In
addition, incomplete lineage sorting could result in alternate
retention of ancestral A3G alleles, leading to an apparent para-
phyly. Alternatively, the incongruent A3G phylogeny may be
explained by selection. The fact that residues in A3G that interact
with Vif are undergoing positive selection in primates (Ortiz et al.,
2006) is further evidence that Vif-mediated antagonism is
capable of selecting for genetic change in A3G. In addition,
long-term balancing selection can maintain ancestral gene
polymorphism across diverged populations due to a survival/
reproductive advantage conferred to heterozygous individuals.
The adaptive inferiority of Vif isolated from monkey V038,
despite expressing one copy of A3Gvariant VIII D130H (Figure 4),
suggests that A3G heterozygosity may apply an adaptive
constraint on the virus. The relative lack of viral adaptation in
this animal demonstrates that the broadening of Vif specificity
in order to accommodate multiple A3G variants may come at
a considerable cost, which is likely to decelerate viral adaptation.
This is supported by the branching order of the Vif phylogenetic
tree, in which V038 Vif sequences are split into two clades (Fig-
ure 4A, triangles). We postulate that a lack of directional selec-
tion in these viral sequences results from the requirement that
Vif must counteract two distinct A3G variants in a heterozygous
animal.
Host-Virus Adaptation
A recent report demonstrated that the outcome of experimental
cross-species transmission of SIV in rhesus macaques is largely
dependent on the TRIM5a genotype of the recipient monkey
(Kirmaier et al., 2010). Furthermore, TRIM5a-resistant virus
emerged in some of the infected monkeys, demonstrating that
adaptation in the capsid (CA) region of Gag facilitates escape
from TRIM5a-mediated restriction in vivo.We employed a similar
approach to demonstrate that Vif counterevolves in vivo tonc.
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mental infections are unlikely to reproduce the natural dynamics
of host-virus coevolution, we show that A3G-driven evolution of
Vif is a naturally occurring phenomenon because the specificity
of Vif proteins from SIVagm subtypes reflects adaptation to
subspecies-specific A3G variants in AGM populations exposed
to SIV in the wild rather than in the laboratory.
There is not a direct correlation between A3G genotype and
viral load in this small cohort (Goldstein et al., 2006). Thus,
A3G is not the sole determinant of clinical outcome in this
virus-host setting. Nonetheless, by tracking viral evolution in
SIV-infected monkeys, we have shown that adaptation in Vif
occurs upon infection of monkeys expressing naturally occurring
variants of A3G, demonstrating that A3G has the potential to set
the course of viral evolution in vivo. By analyzing intraspecies
A3G variation in a natural host of SIV, we have now demon-
strated a case of contemporary selection and adaptation
between primate lentiviruses and their natural primate hosts.
EXPERIMENTAL PROCEDURES
PCR Amplification of Primate Genes
Sources of AGM samples are described in Table S1. Whole RNA and genomic
DNA (gDNA) were extracted from AGM peripheral blood mononuclear cells or
AGM-derived continuous cell lines using the RNeasyMini Kit (QIAGEN) and the
Whole Blood DNA Isolation Kit (QIAGEN), respectively. Partial mitochondrial
genes Cytochrome B and NADH1 were PCR amplified (see Table S2 for oligo
sequences) from gDNA, and bulk PCR products were sequenced. A3G was
amplified via two-step RT-PCR, in which cDNA was synthesized from whole
RNA using the SuperScript II Reverse-Transcriptase Kit (Invitrogen) and
oligo-dT primers (Invitrogen). cDNA was used as template in PCR using
OWM A3G-specific primers. Bulk PCR product was subcloned, and six to
ten clones were sequenced. If two distinct A3G sequences were detected
from a single RNA sample, the individual was considered to be heterozygous.
When samples were limited to gDNA only, A3G-coding exons (1–8) were
amplified and sequenced individually using primers targeted to noncoding
regions of the locus.
PCR Amplification of SIVagm Vif Genes
Vif genes were PCR amplified from full-length molecular clones SIVsab-1 and
SIVtan.1 and from plasma derived from monkeys infected with SIVgri.667 and
SIVver90. In the latter cases, viral RNA was isolated using the QIAamp Viral
RNA Mini Kit (QIAGEN) and used as template in two-step RT-PCR with Vif-
specific primers containing MluI and XbaI restriction sites (Table S2). SIVver90
Vif derived from experimentally infected sabaeus monkeys was amplified
using a nested RT-PCR approach. One to twomilliliters of plasmawas concen-
trated by centrifugation for 30 min at 16,000 rpm. Viral RNA was isolated using
the QIAamp Viral RNA Mini Kit (QIAGEN). Using specific primers that were
targeted to SIVagmVer90 integrase and vpr, Vif was amplified using a one-
step RT-PCR. Products were amplified in a second round of PCR using nested
primers containing MluI and XbaI restriction sites.
Phylogenetic Analysis
A3G and mtDNA sequences were subjected to phylogenetic analysis using
a Bayesian Monte Carlo Markov chain (MCMC) approach implemented in
BEAST v1.6.1. Sequence alignments were executed using ClustalX. Partial
Cytochrome B (273 bp) and NADH1 (298 bp) sequences were concatenated
and subjected to 50,000,000MCMCgenerations using the HKY85 substitution
model, gamma site heterogeneity model, and estimated base frequencies. The
following AGM mtDNA GenBank submissions were included to guide classifi-
cation efforts: EF597500, EF597501, EF597502, EF597503, AY863426, and
DQ069713. We used the constant population size coalescent as the tree prior.
The resulting phylogenieswere annotated using TreeAnnotator,with a ‘‘burnin’’
of 40 and a posterior probability limit of 0.5. A3G sequences were treated
similarly, except 100,000,000 MCMC generations were performed. Addition-Cell Hally, phylogenetic analysis by maximum likelihood (ML) was performed using
the Phylogeny.fr web service. ML trees were imported into PAUP*, and trees
were scored for log likelihood using the Shimodaira-Hasegawa (SH) test.
Test parameters were estimated using 1000 RELL replicates.
A3G Expression Plasmids
Full-length reconstruction of haplotypes originating from grivet monkeys
(hap V and VII) was performed by mutagenesis of other AGM A3G haplotypes
using theQuikChange Site-DirectedMutagenesis Kit (Stratagene). Haplotypes
I–VIII were appended with a 50 hemagluttinin (HA) tag by PCR and cloned into
the mammalian expression vector pcDNA3.1. Site-directed mutagenesis was
used to generate the E128K and H130D A3G mutants.
Recombinant HIV-1 Proviral Plasmids
SIVagm Vif sequences were appended with a 50 Kozac sequence and
50 MluI and 30 XbaI restriction sites by PCR and cloned into the HIV-1DVif
molecular clone (pLai3DEnvLuc2DVif, generated after NdeI-StuI deletion in
pLai3DEnvLuc2). The resulting proviral plasmids lack Env, have a firefly lucif-
erase gene inserted into Nef, and encode SIVagm Vif in the context of the
HIV-1 backbone.
Single-Round Viral Infectivity Assays
293T cells were plated in 1 ml in 12-well plates at 2.5 3 105 cells/mL. The
following day, cells were cotransfected with 0.4 mg of A3G expression plasmid
or an empty expression plasmid, 0.1 mg of L-VSV-G (vesicular stomatitis virus
glycoprotein, for pseudotyping), and 0.6 mg of proviral plasmid in a 100 ml
transfection volume with TransIT-LT1 lipid transfection reagent (Mirus Bio).
Virus supernatants were harvested at 48 hr and clarified by centrifugation for
5 min at 1,800 rpm. The total amount of virus was quantified by p24 Gag
enzyme-linked immunosorbent assay (Advanced Bioscience Laboratories).
Four nanograms of virus was used to infect supT1 cells plated at 3.8 3 105
cells/mL in the presence of 20 mg/mL DEAE-Dextran. Infections were per-
formed in triplicate for 48 hr. Luciferase activity was measured with 100 ml of
Bright-Glo Luciferase Assay Reagent (Promega).
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